PJP transforms proteins, peptides and delicate small molecules into drugs. It also designs optimised pharmaceutical formulations and delivery systems that are stable, convenient and safe.
The company develops manufacturing processes and transfers those from its own pilot labs to large-scale manufacturing.
PJP managing director and founder Klaus Hellerbrand said they started their operations with an experienced team of biopharmaceutical professionals and already are working on several exciting projects.